“President Trump has vowed to lower the cost of prescription drugs. A Senate committee has approved a bipartisan bill to do just that. And the plan is going nowhere fast,” Politico reports.
“With Democrats in control of the House, the GOP-controlled Senate has shifted virtually its entire focus to confirming Trump’s judicial nominees where bipartisan votes aren’t needed. And heading into an election year, McConnell is loath to bring up issues that divide his caucus or risk alienating powerful industry groups. Legislative activity will only decline further if and when the Senate holds an impeachment trial that will further polarize the Capitol.”
Save to Favorites